{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:51:51Z","timestamp":1767707511059},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2018,3,14]]},"abstract":"<jats:sec>\n<jats:title>Background: <\/jats:title>\n<jats:p>The longitudinal change of neuropsychological tests (NPTs) in treated Alzheimer's\ndisease (AD) is essential to understand the interplay of a therapeutic response from medication\nand a disease decline due to degenerative processes. The aim of our study is to investigate the annual\ncognitive progression as measured by commonly used NPTs in treated AD patients and to assess the potential\npredictors of disease progression.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> Participants (N=455) diagnosed with AD and treated with cholinesterase inhibitors (ChEIs) or\nmemantine at memory clinics in three hospitals in southern Taiwan from January 2009 to December\n2014 were enrolled in this prospectively registered study. The mean follow-up duration was 3.2 \u00b1 0.9\nyears. The patients' severity of AD ranged from very mild (clinical dementia rating (CDR) scales = 0.5)\nto moderate (CDR = 2.0). At baseline and for each year, participants were assessed by various NPTs\ncommonly used in clinical practice, including the Mini-Mental State Examination (MMSE), Cognitive\nAbilities Screening Instrument (CASI), CDR and CDR-sum of boxes (CDR-SB). All enrolled participants\nwere assessed for at least two years during follow-up. We used mixed-effect models to examine\nannual progression in the whole group and to compare the cognitive progression between the subgroups\nwith very mild AD and mild to moderate AD. Potential predictors of disease progression, including age,\ngender, the type of ChEI, and Apolipoprotein E (APOE) genotype, were also analyzed.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> Among the study population, the rate of change in MMSE scores were -1.15 points per year,\nCASI scores were -4.27 points per year, and CDR-SB scores were 0.81 points per year. The slope of\nannual changes of NPTs differed significantly between the CDR 0.5 group and the CDR 1 to 2 group.\nThe most significant predictors of the faster progression were increasing age and higher CDR stage at\nentry; however, different types of ChEI therapy (donepezil vs. rivastigmine users), and APOE genotype\nwere not associated with the rate of disease progression.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions: <\/jats:title>\n<jats:p>This longitudinal data shows the mean annual change of the MMSE, CASI, CDR, and\nCDR-SB in treated AD patients. The data may provide clinicians with information regarding to the cognitive\ndecline rate in every year while their AD patients receive approved pharmacological therapy in\nreal-world practice. Increasing age and severity of dementia when receiving therapy are the main factors\nthat associated with faster deterioration.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567205014666171010112518","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T05:03:12Z","timestamp":1508216592000},"page":"474-481","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication"],"prefix":"10.2174","volume":"15","author":[{"given":"Yuan-Han","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Ni","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Song","family":"Chou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Chen","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Cheng Kung University Hospital, Tainan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Hsiang","family":"Lin","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pi-Shan","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Cheng Kung University Hospital, Tainan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/156310","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/156310\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/156310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T16:00:41Z","timestamp":1609257641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/156310\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,3,14]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567205014666171010112518","relation":{},"ISSN":["1567-2050"],"issn-type":[{"value":"1567-2050","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3,14]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-06-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}